Analysis of the CCR5 gene coding region diversity in five South American populations reveals two new non-synonymous alleles in Amerindians and high CCR5*D32 frequency in Euro-Brazilians

Genetics and Molecular Biology

Volumn 32, Issue 1, 2009, Pages 12-19

  Boldt, Angelica B W ^a,b   Culpi, Lodércio ^a   Tsuneto, Luiza T ^a,c   Souza, Ilíada R ^a,d   Kun, Jürgen F J ^a,d   Petzl Erler, Maria Luiza ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c STATE UNIVERSITY OF MARINGÁ   (Brazil)

^d FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Amerindian; Brazilian; CCR5; HIV; Polymorphism

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ARTICLE; BRAZIL; CONTROLLED STUDY; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC CODE; GENETIC DIFFERENCE; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; SOUTH AMERICA; SOUTH AND CENTRAL AMERICA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 66649132792     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572009005000011     Document Type: Article

References (46)

1. Accetturi CA, Pardini R, Novaes Pinto GH, Turcato Jr G, Lewi DS and Diaz RS (2000) Effects of CCR5 genetic polymorphism and HIV-1 subtype in antiretroviral response in Brazilian HIV-1-infected patients. J Acquir Immune Defic Syndr 24:399-400.
2. Ansari-Lari MA, Liu XM, Metzker ML, Rut AR and Gibbs RA (1997) The extent of genetic variation in the CCR5 gene. Nat Genet 16:221-222.
3. Blanpain C, Lee B, Tackoen M, Puffer B, Boom A, Libert F, Sharron M, Wittamer V, Vassart G, Doms RW, et al. (2000) Multiple nonfunctional alleles of CCR5 are frequent in various human populations. Blood 96:1638-1645.
4. Blanpain C, Wittamer V, Vanderwinden JM, Boom A, Renneboog B, Lee B, Le Poul E, El Asmar L, Govaerts C, Vassart G, et al. (2001) Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways. J Biol Chem 276:23795-23804.
5. Boldt AB and Petzl-Erler ML (2002) A new strategy for mannose-binding lectin gene haplotyping. Hum Mutat 19:296-306.
6. Brajão de Oliveira K, Reiche EM, Kaminami MH, Pelegrinelli Fungaro MH, Estevão D, Pontello R, Franco NT and Watanabe MA (2007) Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis. J Cutan Pathol 34:27-32.
7. Braun-Prado K, Vieira Mion AL, Farah PN, Culpi L and Petzl-Erler ML (2000) HLA class I polymorphism, as characterised by PCR-SSOP, in a Brazilian exogamic population. Tissue Antigens 56:417-427.
8. Brito AM, Castilho EA and Szwarcwald CL (2005) Regional patterns of the temporal evolution of the AIDS epidemic in Brazil following the introduction of antiretroviral therapy. Braz J Infect Dis 9:9-19.
9. Brumme ZL, Goodrich J, Mayer HB, Brumme CJ, Henrick BM, Wynhoven B, Asselin JJ, Cheung PK, Hogg RS, Montaner JS, et al. (2005) Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals. J Infect Dis 192:466-474.
10. Calzada JE, Nieto A, Beraun Y and Martin J (2001) Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy. Tissue Antigens 58:154-158.
11. Carrington M, Kissner T, Gerrard B, Ivanov S, O'Brien SJ and Dean M (1997) Novel alleles of the chemokine-receptor gene CCR5. Am J Hum Genet 61:1261-1267.
12. Chies JA and Hutz MH (2003) High frequency of the CCR5delta32 variant among individuals from an admixed Brazilian population with sickle cell anemia. Braz J Med Biol Res 36:71-75.
13. De Pinho Lott Carvalhaes FA, Cardoso GL, Hamoy IG, Liu YT and Guerreiro JF (2004) Distribution of CCR5-delta32, CCR2-64I, and SDF1-3′ A mutations in populations from the Brazilian Amazon region. Hum Biol 76:643-646.
14. de Souza PR, Arraes LC, Lima Filho JL, Bruneska D, Milanese M and Crovella S (2006) CCR5 promoter polymorphisms and HIV-1 perinatal transmission in Brazilian children. J Reprod Immunol 69:77-84.
15. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia growth and development study, multicenter AIDS cohort study, multicenter hemophilia cohort study, San Francisco City cohort, ALIVE study. Science 273:1856-1862.
16. Desgranges C, Carvajal P, Afani A, Guzman MA, Sasco A and Sepulveda C (2001) Frequency of CCR5 gene 32-basepair deletion in Chilean HIV-1 infected and non-infected individuals. Immunol Lett 76:115-117.
17. Diaz FJ, Vega JA, Patino PJ, Bedoya G, Nagles J, Villegas C, Vesga R and Rugeles MT (2000) Frequency of CCR5 delta-32 mutation in human immunodeficiency virus (HIV)-sero-positive and HIV-exposed seronegative individuals and in general population of Medellin, Colombia. Mem Inst Oswaldo Cruz 95:237-242.
18. Excoffier L, Laval G and Schneider S (2005) Arlequin v. 3.0: An integrated software package for population genetics data analysis. Evol Bioinf Online 1:47-50.
19. Fernandez-Vina MA and Bignon JD (1997) Primers and oligonucleotide probes (SSOP) used for DNA typing of HLA class II alleles. In: Charron D (ed) HLA: Genetic Diversity of HLA Functional and Medical Implication. 1st edition. EDK, Paris, pp 199-215.
20. Ferraro GA, Mello MA, Sutmoller F, Van Weyenbergh J, Shindo N, Galvao-Castro B and Bou-Habib DC (2001) Biological characterization and chemokine receptor usage of HIV type 1 isolates prevalent in Brazil. AIDS Res Hum Retroviruses 17:1241-1247.
21. Gonzalez E, Dhanda R, Bamshad M, Mummidi S, Geevarghese R, Catano G, Anderson SA, Walter EA, Stephan KT, Hammer MF, et al. (2001) Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: Impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci USA 98:5199-5204.
22. Grimaldi R, Shindo N, Acosta AX, Dourado I, Brites C, de Melo CO, Brito I, Bou-Habib DC and Galvão-Castro B (2002) Prevalence of the CCR5Delta32 mutation in Brazilian populations and cell susceptibility to HIV-1 infection. Hum Genet 111:102-104.
23. Guerin S, Meyer L, Theodorou I, Boufassa F, Magierowska M, Goujard C, Rouzioux C, Debre P and Delfraissy JF (2000) CCR5 delta32 deletion and response to highly active antiretroviral therapy in HIV-1-infected patients. AIDS 14:2788-2790.
24. Hisada M, Lal RB, Masciotra S, Rudolph DL, Martin MP, Carrington M, Wilks RJ and Manns A (2002) Chemokine receptor gene polymorphisms and risk of human T lymphotropic virus type I infection in Jamaica. J Infect Dis 185:1351-1354.
25. Howard OM, Shirakawa AK, Turpin JA, Maynard A, Tobin GJ, Carrington M, Oppenheim JJ and Dean M (1999) Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 Co-receptor and ligand binding function. J Biol Chem 274:16228-16234.
26. Hunemeier T, Neves AG, Nornberg I, Hill K, Hurtado AM, Carnese FR, Goicoechea AS, Hutz MH, Salzano FM and Chies JA (2005) T-cell and chemokine receptor variation in South Amerindian populations. Am J Hum Biol 17:515-518.
27. Kaimen-Maciel DR, Reiche EM, Brum Souza DG, Frota Comini ER, Bobroff F, Morimoto HK, Ehara Watanabe MA, Carvalho DO, Matsuo T, Lopes J, et al. (2007) CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis. Int J Mol Med 20:337-344.
28. Leboute AP, de Carvalho MW and Simões AL (1999) Absence of the deltaccr5 mutation in indigenous populations of the Brazilian Amazon. Hum Genet 105:442-443.
29. Mangano A, Theiler G, Sala L, Capucchio M, Fainboim L and Sen L (2001) Distribution of CCR5-Delta 32 and CCR2-64I alleles in an Argentine Amerindian population. Tissue Antigens 58:99-102.
30. Mummidi S, Ahuja SS, McDaniel BL and Ahuja SK (1997) The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5′-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons. J Biol Chem 272:30662-30671.
31. Munerato P, Azevedo ML, Sucupira MC, Pardini R, Pinto GH, Catroxo M, Souza IE and Diaz RS (2003) Frequency of polymorphisms of genes coding for HIV-1 co-receptors CCR5 and CCR2 in a Brazilian population. Braz J Infect Dis 7:236-240.
32. Navratilova Z (2006) Polymorphisms in CCL2&CCL5 chemokines/chemokine receptors genes and their association with diseases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150:191-204.
33. Passos Jr GA and Picanço VP (1998) Frequency of the delta ccr5 deletion allele in the urban Brazilian population. Immunol Lett 61:205-207.
34. Pauls Jr P (1976) Witmarsum in Paraná. 1st edition. Imprimax, Curitiba, 50 pp.
35. Petzl-Erler ML, Luz R and Sotomaior VS (1993) The HLA polymorphism of two distinctive South-American Indian tribes: The Kaingang and the Guarani. Tissue Antigens 41:227-237.
36. Probst CM, Bompeixe EP, Pereira NF, de O Dalalio MM, Visentainer JE, Tsuneto LT and Petzl-Erler ML (2000) HLA polymorphism and evaluation of European, African, and Amerindian contribution to the white and mulatto populations from Paraná, Brazil. Hum Biol 72:597-617.
37. Shioda T, Nakayama EE, Tanaka Y, Xin X, Liu H, Kawana-Tachikawa A, Kato A, Sakai Y, Nagai Y and Iwamoto A (2001) Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5. J Virol 75:3462-3468.
38. Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M, Winkler C, Huttley GA, Allikmets R, Schriml L, et al. (1998) Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet 62:1507-1515.
39. Suslov KV (2004) Does AID aid AIDS? Immunol Lett 91:1-2.
40. Szwarcwald CL, Bastos FI, Esteves MA and de Andrade CL (2000) The spread of the AIDS epidemic in Brazil from 1987 to 1996: A spatial analysis. Cad Saúde Pública 16:7-19.
41. Tamasauskas D, Powell V, Saksela K and Yazdanbakhsh K (2001) A homologous naturally occurring mutation in Duffy and CCR5 leading to reduced receptor expression. Blood 97:3651-3654.
42. Tsuneto LT, Probst CM, Hutz MH, Salzano FM, Rodriguez-Delfin LA, Zago MA, Hill K, Hurtado AM, Ribeiro-dos-Santos AK and Petzl-Erler ML (2003) HLA class II diversity in seven Amerindian populations. Clues about the origins of the Ache. Tissue Antigens 62:512-526.
43. Vargas AE, Marrero AR, Salzano FM, Bortolini MC and Chies JA (2006) Frequency of CCR5delta32 in Brazilian populations. Braz J Med Biol Res 39:321-325.
44. Yudin NS, Vinogradov SV, Potapova TA, Naykova TM, Sitnikova VV, Kulikov IV, Khasnulin VI, Konchuk C, Vloschinskii PE, Ivanov SV, et al. (1998) Distribution of CCR5-delta 32 gene deletion across the Russian part of Eurasia. Hum Genet 102:695-698.
45. Zhao XY, Lee SS, Wong KH, Chan KC, Ng F, Chan CC, Han D, Yam WC, Yuen KY, Ng MH, et al. (2005) Functional analysis of naturally occurring mutations in the open reading frame of CCR5 in HIV-infected Chinese patients and healthy controls. J Acquir Immune Defic Syndr 38:509-517.
46. Zuniga JA, Villarreal-Garza C, Flores E, Barquera R, Perez-Hernandez N, Montes de Oca JV, Cardiel MH, Vargas-Alarcon G and Granados J (2003) Biological relevance of the polymorphism in the CCR5 gene in refractory and non-refractory rheumatoid arthritis in Mexicans. Clin Exp Rheumatol 21:351-354.